210 related articles for article (PubMed ID: 8609564)
1. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH
J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564
[TBL] [Abstract][Full Text] [Related]
2. In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.
Siegal T; Rubinstein R; Bokstein F; Schwartz A; Lossos A; Shalom E; Chisin R; Gomori JM
J Neurosurg; 2000 Apr; 92(4):599-605. PubMed ID: 10761648
[TBL] [Abstract][Full Text] [Related]
3. Quantification and pharmacokinetics of blood-brain barrier disruption in humans.
Zünkeler B; Carson RE; Olson J; Blasberg RG; DeVroom H; Lutz RJ; Saris SC; Wright DC; Kammerer W; Patronas NJ; Dedrick RL; Herscovitch P; Oldfield EH
J Neurosurg; 1996 Dec; 85(6):1056-65. PubMed ID: 8929495
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological aspects of malignant brain tumors studied with positron emission tomography.
Jarden JO
Acta Neurol Scand Suppl; 1994; 156():1-35. PubMed ID: 7941966
[TBL] [Abstract][Full Text] [Related]
5. Effect of hyperosmotic blood-brain barrier disruption on transcapillary transport in canine brain tumors.
Groothuis DR; Warkne PC; Molnar P; Lapin GD; Mikhael MA
J Neurosurg; 1990 Mar; 72(3):441-9. PubMed ID: 2106016
[TBL] [Abstract][Full Text] [Related]
6. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
Brown RC; Egleton RD; Davis TP
Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006
[TBL] [Abstract][Full Text] [Related]
7. The effects of pentobarbital on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Chun TW; Liu X; Weiss HR
Anesth Analg; 1998 Jun; 86(6):1230-5. PubMed ID: 9620510
[TBL] [Abstract][Full Text] [Related]
8. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
[TBL] [Abstract][Full Text] [Related]
9. Measurement of blood-brain barrier permeability with positron emission tomography and [68Ga]EDTA.
Kessler RM; Goble JC; Bird JH; Girton ME; Doppman JL; Rapoport SI; Barranger JA
J Cereb Blood Flow Metab; 1984 Sep; 4(3):323-8. PubMed ID: 6432806
[TBL] [Abstract][Full Text] [Related]
10. The effects of the Na(+)/Ca(++) exchange blocker on osmotic blood-brain barrier disruption.
Bhattacharjee AK; Nagashima T; Kondoh T; Tamaki N
Brain Res; 2001 May; 900(2):157-62. PubMed ID: 11334793
[TBL] [Abstract][Full Text] [Related]
11. Effects of intracarotid hyperosmolar mannitol in triethyl tin (TET)-induced rat brain edema--preservation of blood-brain barrier (BBB) in TET edema.
Inoue T; Nagara H; Kondo A; Fukui M; Tateishi J
Brain Res; 1987 Jun; 414(2):309-13. PubMed ID: 3113663
[TBL] [Abstract][Full Text] [Related]
12. [Blood-brain barrier opening microcirculation in human brain tumor].
Sato S; Toya S; Otani M
No To Shinkei; 1985 Feb; 37(2):109-13. PubMed ID: 2988587
[TBL] [Abstract][Full Text] [Related]
13. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
[TBL] [Abstract][Full Text] [Related]
14. Comparison of various methods for delivering radiolabeled monoclonal antibody to normal rat brain.
Bullard DE; Bourdon M; Bigner DD
J Neurosurg; 1984 Nov; 61(5):901-11. PubMed ID: 6436447
[TBL] [Abstract][Full Text] [Related]
15. Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate.
Sage MR; Wilcox J; Evill CA; Benness GT
Invest Radiol; 1982; 17(3):276-81. PubMed ID: 6811497
[TBL] [Abstract][Full Text] [Related]
16. Osmotic blood-brain barrier disruption: pharmacodynamic studies in dogs and a clinical phase I trial in patients with malignant brain tumors.
Neuwelt EA; Hill SA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Lewis SE; Ehle AL; Beyer CW
Cancer Treat Rep; 1981; 65 Suppl 2():39-43. PubMed ID: 6809316
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyethyl starch solution attenuates blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Lu X; Wei HM; Williams JA; Weiss HR
Anesth Analg; 1996 Aug; 83(2):336-41. PubMed ID: 8694315
[TBL] [Abstract][Full Text] [Related]
18. Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery.
Neuwelt EA; Maravilla KR; Frenkel EP; Rapaport SI; Hill SA; Barnett PA
J Clin Invest; 1979 Aug; 64(2):684-8. PubMed ID: 457877
[TBL] [Abstract][Full Text] [Related]
19. Intravenous mannitol does not increase blood-brain barrier permeability to inert dyes in the adult rat forebrain.
Chen KB; Wei VC; Yen LF; Poon KS; Liu YC; Cheng KS; Chang CS; Lai TW
Neuroreport; 2013 Apr; 24(6):303-7. PubMed ID: 23426109
[TBL] [Abstract][Full Text] [Related]
20. The effects of morphine on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Chi OZ; Lee DI; Liu X; Weiss HR
Anesth Analg; 2000 Mar; 90(3):603-8. PubMed ID: 10702444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
